Author Details

Defronzo, Ralph A

  • Vol 15, No 4 (2015) - Editorials
    Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin
    Details  HTML  PDF
  • Vol 17, No 4 (2017) - Editorials
    Diabetes medications with cardiovascular protection in the wake of EXSCEL: is there a class effect for long-acting GLP-1 receptor agonists?
    Details  HTML  PDF